Replies to post #78422 on Innovation Pharmaceuticals Inc (IPIX)
11/16/14 11:15 AM
11/16/14 11:16 AM
11/16/14 12:27 PM
Note received from Leo today regarding uplisting. I'm thinking he sent it to me since I had put a call in to him on Friday. I'd been thinking of asking for another interview, but, our call was cut short by another before I could ask for an interview. The only question I got out was about uplisting. I think others have asked too. Following is a cut and paste without any changes:
Uplisting question
Leo Ehrlich
7:36 AM (24 minutes ago)
to me
Please understand that this matter is always at the forefront of Cellceutix's plans. Of course I would like to attract institutional ownership, and hope the share price will rise as a result. After all, I am also a very large shareholder of CTIX.
I assure you I have a mostly completed NASDAQ application on my desk. However, before applying there are factors that we must consider for the best long term value for Cellceutix and its shareholders. A basic requirement is that we have the capital on hand to complete one year of projects and can't have a going concern opinion from the auditors. (The same is true for NYSE-MKT). To accomplish that I would need to dilute quite heavily at the present price of about $3/share.
Considering the recent announcements on the ABSSSI and Kevetrin trials, and the recent purchase of Durata at such an astonishing price, do you think it would be wise to do so? Perhaps its prudent to wait a little longer and hopefully the market will better reflect our value. Of course at any time we think its right, we may pull the trigger and apply.
These are the kind of decisions we need to make for the best interest's of Cellceutix and its shareholders. That is why we have filed a S-3 for a shelf offering. If shorts think they can can cover with cheaper shares because of this filing, they may be in for a surprise as we will always do whats best for Cellceutix and its shareholders.
Best, Leo Ehrlich
11/16/14 4:51 PM
11/17/14 11:35 AM
| Volume | |
| Day Range: | |
| Bid Price | |
| Ask Price | |
| Last Trade Time: |